Hamilton Health Sciences Corporation
Clinical trials sponsored by Hamilton Health Sciences Corporation, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a diabetes drug tame a rare heart rhythm disorder? Results expected Feb 2027 (estimated)
- AI and dye join forces to spot leaky gut in IBD patients Results expected Feb 2027 (estimated)
- Can a simple drug stop dangerous bleeding in kidney patients during surgery? Results expected Feb 2027 (estimated)
- Could a poop pill help teens with anorexia? Results expected Jun 2027 (estimated)
-
Can a diabetes drug also protect the hearts and prostate of men on hormone therapy?
Disease control OngoingMen with prostate cancer often receive androgen deprivation therapy, which can raise the risk of heart problems and metabolic issues. This trial tests whether adding semaglutide, a GLP-1 receptor agonist, can control cardiovascular risk factors like weight, blood pressure, and ch…
Phase 4 • Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Heart bypass upgrade: which Artery-Harvesting technique works best?
Disease control CancelledThis trial tests two methods of harvesting the left internal mammary artery for heart bypass surgery. One method strips the artery clean of surrounding tissue; the other leaves the tissue intact. Researchers want to know which approach keeps the graft open longer and reduces the …
Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC